Search Results

Containing any of the words

Only of the type

A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study To Assess The Efficacy And Safety of Induction and Maintenance Therapy with Ro7790121 in Patients with Moderately to Severely Active Crohn's Disease Drug Clinical Trial

Biotin,Cyanocobalamin,Folic Acid,Nicotinamide,Pyridoxine (Vitamin B6),Riboflavin,Sodium Ascorbate,Sodium Pantothenate,Thiamine New SFDA Drug Approvals

A Randomized, Open-Label, Phase 3 Study of Abemaciclib combined with Standard Adjuvant Endocrine Therapy versus Standard Endocrine Therapy Alone in Patients with High Risk Node Positive Early Stage Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer Drug Clinical Trial

"Prospective Observational Clinical Practice Study in the 1st LineManagement of mCRC with Erbitux ™ in combination with Chemotherapy" Drug Clinical Trial

Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia Drug Clinical Trial

Psoriasis Study of Health Outcomes (PSoHO) – an International Observational Study of 3-Year Health Outcomes in the Biologic Treatment of Moderate-to-Severe Plaque Psoriasis Drug Clinical Trial

A Randomized, Open-Label, Phase 3 Study of Abemaciclib combined with Standard Adjuvant Endocrine Therapy versus Standard Endocrine Therapy Alone in Patients with High Risk Node Positive Early Stage Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer Drug Clinical Trial

(SG-1807-14-H) Urgent FSN of Percepta™ CRT-P MRI SureScan™ and Percepta™ Quad CRT-P MRI SureScan™ Pacemakers Manufactured by Medtronic Medical Report

(SG-1808-19-H) Urgent FSN’s of THERA-Trainer balo, BALANCE-Trainer, THERA-Trainer verto Manufactured by Medica Medizintechnik GmbH Medical Report

A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 Drug Clinical Trial